CFTR | Page 4 | European Cystic Fibrosis Society (ECFS)

Combination potentiator ('co-potentiator') therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators.

Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity.

Detection of CFTR Function and Modulation in Primary Human Nasal Cell Spheroids

A Multiple Reader Scoring System for Nasal Potential Difference Parameters

CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis

AP2 α modulates cystic fibrosis transmembrane conductance regulator function in the human intestine

Monocyte derived macrophages from CF pigs exhibit increased inflammatory responses at birth

Peripheral muscle abnormalities in cystic fibrosis: etiology, clinical implications and response to therapeutic interventions

Standards and guidelines for CFTR mutation testing

Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders – updated European recommendations

first
previous
1
2
3
4
5
next
last